Lund, February 4th, 2014
For release 3:00 p.m. CET, 9:00 a.m. EST, February 4th, 2014
TFS Appoints two Executive VP Positions
TFS Appoints Mr. Roy Ovel as Executive VP Global Business Development and Ms. Thea Wesseling as Executive VP Global Clinical Development
TFS International announced today the appointment of two global Executive Vice Presidents in Business Development and Clinical Development to further strengthen the company’s commercial activities and operational excellence. Both positions will be a part of the Global Management Team and will report to Mr. Daniel Spasic, CEO at TFS International.
"We are proud to announce that Roy Ovel and Thea Wesseling have joined the TFS Group bringing a wealth of experience within their respective fields. The importance and focus on our Human Capital is critical to our continued success as our business is rapidly becoming a truly global one where we see project complexity and customer expectations increasing", says Mr. Daniel Spasic, CEO.
Roy Ovel joins TFS as EVP Global Business Development. He brings more than 25 years of international business development experience with some of the leading global CROs. Roy will head up the TFS business development teams in Europe and US including sales, marketing, proposals and contracts.
"I was pleased to join TFS, as it is a company that is very entrepreneurial and highly focused on collaborating with its partners to provide flexible, tailored solutions at the regional and global level. TFS has one of the broadest service portfolios among the midsized CROs and can support Functional Services, early and pivotal outsourced studies as well as provide leading capabilities in post-marketing trials and NIS. The people at TFS are highly motivated and professional with a real "can do" attitude. It is these qualities that will ensure success for our partners and will support the growth of the company in the coming years", says Mr. Roy Ovel, EVP Global Business Development.
As EVP Global Clinical Development with TFS, Thea Wesseling brings more than 15 years working at global executive positions with Quintiles where she was responsible for their CNS/psychiatry franchise. In addition, she has held numerous different VP roles within global clinical development over the years. In her new role at TFS, Thea will be responsible for heading up the global functions in clinical operations, biometrics, medical affairs and project controlling.
"I was intrigued by the company’s growth story and the level of customer focus throughout the organization. I’m impressed by the personnel’s talent and their complete engagement. It feels exciting and challenging to join such a dynamic company that is moving towards becoming a very interesting global company. I’m looking forward to sharing my global development experience and further building our operational excellence throughout the many projects and customers we serve", says Ms. Thea Wesseling, EVP Global Clinical Development.
For further information please contact:
Ms. Gordana Claveres, MSc.
Marketing and Communications Associate